Information Provided By:
Fly News Breaks for June 8, 2018
MDRX
Jun 8, 2018 | 07:47 EDT
Cantor Fitzgerald analyst Steven Halper continues to believe that Allscripts' growth outlook has improved after a series of strategic acquisitions. The stock offers 43% upside potential to $18, Halper tells investors in a research note. He finds the stock attractive and reiterates an Overweight rating on the name with an $18 price target.
News For MDRX From the Last 2 Days
There are no results for your query MDRX